Purchase Order W81XWH22P0102
Award Date 6/30/22
Potential Completion Date 12/30/23
Potential Value $250K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Georgia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Technology Management Company, Inc. (T M C), a small business, was issued by the Defense Health Agency (DHA) to provide research and development (R&D) support focused on antimicrobial resistance, enteric infections, acute respiratory infections, acute febrile illnesses, vector surveillance, and phage-based medical countermeasure development within the U.S. European Command area of responsibility. The contract is a single-award, small business set-aside...
- This is a $240,000.00 firm fixed price contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Intralytix Inc., a for-profit biotech organization that specializes in bacteriophage-based products for food safety and public health applications. The contract, which does not have a set-aside designation, is for the "Elucidation of Interaction of Bacteriophages with Bacteria in Various Food Matrixes, and the Impact on the Food...
- This $517,499.04 firm fixed-price federal contract was awarded by the U.S. Army Medical Command to the L Sakvarelidze National Center for Disease Control and Public Health, a non-profit organization, to provide services for "assessing the seroprevalence." The contract has an ultimate completion date of August 15, 2022 and was awarded on August 16, 2017. No set-aside was used for this contract. The contractor provides a range of services to the Department of Defense, including...
- The U.S. Army Combat Capabilities Development Command (CCDC) awarded a $249,970 firm-fixed-price definitive contract to Intralytix Inc. on February 13, 2025, to develop and optimize a stable dry formulation of PhageSafe, a bacteriophage-based antimicrobial preparation targeting three major foodborne bacterial pathogens of concern to the Army: Listeria monocytogenes, Salmonella, and Escherichia coli STEC. The contract, which originated from a Broad Agency Announcement seeking basic and applied...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command (MEDCOM) to Physical Sciences Inc., a for-profit research and development company. The $249,909.42 firm fixed-price contract is for development of a "stabilized, freeze dried bacteriophage for use in austere environments", which aligns with MEDCOM's Topic DHA21C-003 focused on biotechnology innovations. Physical Sciences Inc. specializes in providing a range of...
- The Department of the Army Medical Command awarded a $1,099,973.44 firm fixed price contract to Physical Sciences Inc., doing business as Physical Sciences Inc., for research and development of Stabilized, Freeze-Dried Bacteriophage for Use in Austere Environments under a Small Business Technology Transfer Phase II solicitation. The prime contractor Physical Sciences Inc. will perform the entirety of the contract from its location in Andover, Massachusetts over a period of two years from March...
- The Department of the Army Medical Command awarded a $166,492.05 Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation, doing business as CFD Research, for the development of a "Portable Automated Phage Isolation Technology." This firm-fixed-price contract was set aside for small businesses. CFD Research, a for-profit engineering and technology services firm, has a history of providing computational fluid dynamics research, artificial intelligence,...
- This is a $249,488.02 firm fixed price STTR Phase I research contract awarded by the Department of the Army Medical Command to Guild Associates Inc., doing business as Guild Biosciences, a small business manufacturer of filtration, adsorption, and other products. The contract is for the development of "A Rapid High-Throughput Device to Isolate Antibiofilm Bacteriophage," which supports medical research and development efforts. The contract has a completion date of December 7, 2021...
- The Department of the Army Materiel Command Research Development and Engineering Command awarded a firm fixed price contract valued at ninety-nine thousand nine hundred sixty-eight dollars to The Charles Stark Draper Laboratory, Inc. (Draper) to identify bacteriophages under Task 1 of an unspecified effort. No set-aside designation applied. Performance will occur in Natick, Massachusetts with an anticipated completion date of October 31, 2021. As a not-for-profit research organization, Draper...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command (MEDCOM) to Memsel Inc., a self-certified small disadvantaged business. The $249,918.26 contract is for the development of a multi-component hydrogel containing stabilized, encapsulated bacteriophages for the treatment of drug-resistant bacterial infections. This SBIR Phase I contract was set aside for small businesses and is part of MEDCOM's broader efforts to identify...